Cube Labs SpA

Cube Labs SpA FCF Yield

The Free Cash Flow Yield of Cube Labs SpA (CUBE.MI) as of Oct 27, 2026 is -8.34 %. In the previous year, Free Cash Flow Yield was -4.38 % — a change of 90.56% (lower).

FCF Yield

-8.34 %

YoY

90.56%

Last updated:

Free Cash Flow Yield of Cube Labs SpA is 2025 -8.34 % . Free Cash Flow Yield of Cube Labs SpA was 2024 -4.38 % . It decreases by 90.56% lower compared to the previous year.

The Cube Labs SpA FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2020
-1.03 EUR
Jan 1, 2021
-0.79 EUR
Jan 1, 2022
-3.00 EUR
Jan 1, 2023
-6.67 EUR
Jan 1, 2024
-4.38 EUR
Jan 1, 2025
-8.34 EUR
The Cube Labs SpA FCF Yield history
YEARFCF YieldYoY
-8.34 %+90.56%
-4.38 %-34.40%
-6.67 %+122.46%
-3.00 %+281.33%
-0.79 %-23.42%
-1.03 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cube Labs SpA Stock analysis

What does Cube Labs SpA do? Cube Labs SpA generates revenue through healthcare technology services, focusing on creating and supporting companies from the R&D stage. The firm provides entrepreneurial and operational support for healthcare management and technology solutions, targeting global markets. It promotes and implements scientific research results in human health, biotechnology, and nanotechnology, serving clients seeking innovative healthcare technology integration. The company operates with a lean team of two full-time employees, leveraging its expertise in translating research into practical applications. Cube Labs SpA's business model centers on bridging the gap between scientific research and market-ready healthcare technology. By offering tailored support for startups in the healthcare sector, the company helps clients navigate the complexities of R&D commercialization. Its global operations allow it to serve clients across different regions, capitalizing on the increasing demand for advanced healthcare solutions. The firm's revenue streams are derived from its specialized services in healthcare technology development and implementation. The company's primary clients are healthcare technology startups and established firms looking to integrate scientific research into their operations. Cube Labs SpA supports these clients through its expertise in biotechnology and nanotechnology applications, delivering customized solutions that address specific market needs. With a focus on operational support and entrepreneurial guidance, the firm helps clients accelerate their time-to-market for innovative healthcare products. Cube Labs SpA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cube Labs SpA stock

Free Cash Flow Yield of Cube Labs SpA is -8.34 % in 2025.

Free Cash Flow Yield of Cube Labs SpA changed from -4.38 % to -8.34 %, representing a 90.56% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Cube Labs SpA since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Cube Labs SpA with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cube Labs SpA

All Key Metrics — Cube Labs SpA